Yunnan Energy New Material Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Yunnan Energy New Material has been growing earnings at an average annual rate of 17.2%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 27.2% per year. Yunnan Energy New Material's return on equity is 3%, and it has net margins of 7.8%.
Belangrijke informatie
17.2%
Groei van de winst
15.0%
Groei van de winst per aandeel
Chemicals Groei van de industrie | 12.1% |
Inkomstengroei | 27.2% |
Rendement op eigen vermogen | 3.0% |
Nettomarge | 7.8% |
Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Yunnan Energy New Material Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Nov 03Returns On Capital At Yunnan Energy New Material (SZSE:002812) Paint A Concerning Picture
Oct 25Yunnan Energy New Material Co., Ltd. (SZSE:002812) Surges 41% Yet Its Low P/E Is No Reason For Excitement
Oct 08Does Yunnan Energy New Material (SZSE:002812) Have A Healthy Balance Sheet?
Sep 18Yunnan Energy New Material Co., Ltd.'s (SZSE:002812) Low P/E No Reason For Excitement
Jul 16Is It Too Late To Consider Buying Yunnan Energy New Material Co., Ltd. (SZSE:002812)?
Jun 26Is Yunnan Energy New Material (SZSE:002812) A Risky Investment?
May 26Yunnan Energy New Material's (SZSE:002812) Anemic Earnings Might Be Worse Than You Think
May 02Some Analysts Just Cut Their Yunnan Energy New Material Co., Ltd. (SZSE:002812) Estimates
Apr 30Investors Could Be Concerned With Yunnan Energy New Material's (SZSE:002812) Returns On Capital
Apr 14Is Now The Time To Look At Buying Yunnan Energy New Material Co., Ltd. (SZSE:002812)?
Mar 27Yunnan Energy New Material Co., Ltd. (SZSE:002812) Shares Could Be 27% Below Their Intrinsic Value Estimate
Mar 13Opbrengsten en kosten
Hoe Yunnan Energy New Material geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 10,413 | 817 | 594 | 691 |
30 Jun 24 | 11,257 | 1,413 | 518 | 702 |
31 Mar 24 | 11,801 | 2,036 | 512 | 677 |
31 Dec 23 | 12,042 | 2,527 | 480 | 727 |
30 Sep 23 | 12,405 | 2,928 | 428 | 865 |
30 Jun 23 | 12,403 | 3,385 | 457 | 843 |
31 Mar 23 | 12,567 | 3,734 | 421 | 820 |
01 Jan 23 | 12,591 | 4,000 | 393 | 724 |
30 Sep 22 | 11,923 | 4,188 | 428 | 571 |
30 Jun 22 | 10,345 | 3,687 | 365 | 501 |
31 Mar 22 | 9,132 | 3,201 | 310 | 442 |
01 Jan 22 | 7,982 | 2,718 | 309 | 409 |
30 Sep 21 | 7,041 | 2,228 | 235 | 363 |
30 Jun 21 | 6,236 | 1,844 | 274 | 283 |
31 Mar 21 | 5,173 | 1,409 | 269 | 223 |
31 Dec 20 | 4,283 | 1,116 | 238 | 178 |
30 Sep 20 | 3,635 | 862 | 294 | 164 |
30 Jun 20 | 3,222 | 782 | 228 | 172 |
31 Mar 20 | 3,056 | 776 | 225 | 163 |
31 Dec 19 | 3,160 | 850 | 215 | 155 |
30 Sep 19 | 2,942 | 828 | 223 | 108 |
30 Jun 19 | 2,861 | 746 | 231 | 104 |
31 Mar 19 | 2,683 | 651 | 220 | 103 |
31 Dec 18 | 2,457 | 518 | 211 | 97 |
30 Sep 18 | 2,158 | 397 | 186 | 103 |
30 Jun 18 | 2,123 | 352 | 194 | 91 |
31 Mar 18 | 2,304 | 426 | 177 | 101 |
31 Dec 17 | 2,114 | 368 | 174 | 85 |
30 Sep 17 | 1,919 | 349 | 141 | 44 |
30 Jun 17 | 1,601 | 267 | 132 | 34 |
31 Mar 17 | 1,169 | 160 | 134 | 0 |
31 Dec 16 | 1,146 | 165 | 133 | 0 |
30 Sep 16 | 1,133 | 164 | 125 | 0 |
31 Dec 15 | 1,131 | 150 | 114 | 0 |
31 Dec 14 | 1,217 | 128 | 109 | 0 |
31 Dec 13 | 1,127 | 125 | 98 | 0 |
Kwaliteitswinsten: 002812 has high quality earnings.
Groeiende winstmarge: 002812's current net profit margins (7.8%) are lower than last year (23.6%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 002812's earnings have grown by 17.2% per year over the past 5 years.
Versnelling van de groei: 002812's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 002812 had negative earnings growth (-72.1%) over the past year, making it difficult to compare to the Chemicals industry average (-3.6%).
Rendement op eigen vermogen
Hoge ROE: 002812's Return on Equity (3%) is considered low.